Head and Neck Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Head and Neck Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-11-11Clinical Trial Update: Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors [Phase 1, Phase 2]
Clinical trial update on CAR-T therapy for intermediate and advanced tumors, including melanoma and non-small cell lung cancer, across Phase…
-
CLINICAL_TRIALS trial_result · 2021-11-02Clinical Trial Update: CetuGEX™ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck Cancer [Phase 2]
Phase 2 trial comparing CetuGEX to cetuximab in head and neck squamous cell carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-27Clinical Trial Update: Study to Investigate the Efficacy of Panitumumab in Platinum-resistant Advanced Head and Neck Squamous Cancer [Phase 2]
Phase 2 trial update evaluating panitumumab for platinum-resistant advanced head and neck squamous cell carcinoma has completed.
-
FDA approval · 2021-10-25FDA Approved: METHOTREXATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approves a supplemental application for Methotrexate by Hikma Pharmaceuticals USA Inc., enabling a new generic version of the drug.
-
CLINICAL_TRIALS trial_result · 2021-10-19Clinical Trial Update: NIMRAD (A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab) [Phase 3]
Phase 3 randomized trial evaluating nimorazole plus radiotherapy versus radiotherapy alone in locally advanced head and neck squamous cell c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-10-13Clinical Trial Update: Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer [Phase 3]
Phase III open-label study of MEDI4736 (durvalumab) with/without tremelimumab versus standard of care in recurrent/metastatic head and neck …
-
FDA approval · 2021-09-24FDA Approved: ERBITUX — Supplemental Application (ImClone LLC)
The FDA approved a supplemental application for Erbitux (cetuximab) submitted by ImClone LLC.
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: A Study of LY3435151 in Participants With Solid Tumors [Phase 1]
Phase 1 study of LY3435151 in solid tumors, including triple-negative breast cancer, terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-27Clinical Trial Update: Nimotuzumab Combined With Radiotherapy in High-risk Patients With HNSCC Not Suitable for Cisplatin After Surgery [Phase 2]
Phase 2 trial evaluating nimotuzumab with radiotherapy in high-risk head and neck squamous cell carcinoma patients not eligible for cisplati…
-
CLINICAL_TRIALS trial_result · 2021-08-11Clinical Trial Update: Study of Pembrolizumab Combined With Anlotinib in the First Line Therapy for R/M HNSCC With CPS≥1 [Phase 2]
Phase 2 trial update investigating pembrolizumab plus anlotinib as first-line therapy for recurrent/metastatic head and neck squamous cell c…
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: Durvalumab Plus Tremelimumab Combined With Proton Therapy for HNSCC [Phase 2]
Phase 2 trial evaluating durvalumab plus tremelimumab with proton therapy for head and neck squamous cell carcinoma is reported as ongoing w…
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [Phase 1, Phase 2]
Phase 1/2 trial investigating intratumoral SD-101 with pembrolizumab in metastatic melanoma or recurrent/metastatic head and neck squamous c…
-
FDA approval · 2021-07-01FDA Approved: DOCETAXEL — Original Application (Gland Pharma Limited)
FDA approves Gland Pharma Limited's generic docetaxel as an Original Application, adding a new generic option for cancer chemotherapy.
-
CLINICAL_TRIALS trial_result · 2021-06-01Clinical Trial Update: Evaluation of Afatinib in Maintenance Therapy in Squamous Cell Carcinoma of the Head and Neck [Phase 3]
A Phase 3 clinical trial evaluating afatinib as maintenance therapy for head and neck squamous cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-12Clinical Trial Update: Sintilimab and Nimotuzumab Combined With Chemotherapy for the Treatment of R/M HNSCC. [Phase 2]
Phase 2 clinical trial evaluating sintilimab and nimotuzumab in combination with chemotherapy for recurrent/metastatic head and neck squamou…
-
CLINICAL_TRIALS withdrawal · 2021-05-10Clinical Trial Update: Maintenance Immune Check-point Inhibitor Following Post-operative Chemo-radiation in Subjects With HPV-negative HNSCC [Phase 3]
A Phase 3 trial evaluating maintenance immune checkpoint inhibitor after post-operative chemoradiation in HPV-negative head and neck squamou…
-
CLINICAL_TRIALS trial_result · 2021-05-05Clinical Trial Update: Expansion Trial for Axitinib In Head And Neck Cancer [Phase 2]
Phase 2 expansion trial of axitinib in head and neck squamous cell carcinoma has completed enrollment with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: Image Guided Surgery for Margin Assessment of Head and Neck Cancer Using Cetuximab-IRDye800CW cONjugate [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating image-guided surgery using Cetuximab-IRDye800CW for margin assessment in head and neck squamous cell car…
-
CLINICAL_TRIALS trial_result · 2021-04-27Clinical Trial Update: Camrelizumab as a Maintenance Therapy After Chemoradiation in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating camrelizumab as maintenance therapy after chemoradiation in locally advanced head and neck squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-04-15Clinical Trial Update: Concurrent Immunotherapy With Postoperative Radiotherapy in Intermediate/High Risk HNSCC Patients Unfit for Cisplatin: The IMPORT Study (IMPORT) [Phase 2]
Phase 2 trial evaluating concurrent immunotherapy with postoperative radiotherapy in intermediate/high-risk head and neck squamous cell carc…
-
CLINICAL_TRIALS trial_result · 2021-04-13Clinical Trial Update: DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification of Radiotherapy of HNSCC. [Phase 3]
Phase 3 trial evaluating hypoxia-profile-guided hypoxic modification of radiotherapy in head and neck squamous cell carcinoma; non-inferiori…
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Neoadjuvant Camrelizumab in Combination With Cisplatin and Nab-paclitaxel in Resectable HNSCC [Phase 2]
Phase 2 trial investigating neoadjuvant camrelizumab with cisplatin and nab-paclitaxel in resectable head and neck squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: Pembrolizumab + Radiation for Locally Adv SCC of the Head and Neck (SCCHN) Not Eligible Cisplatin [Phase 2]
Phase 2 trial assessing pembrolizumab with radiation for locally advanced head and neck squamous cell carcinoma in patients not eligible for…
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Concurent Chemoradiotherapy in Head and Neck Cancers [Phase 3]
Phase 3 trial update on concurrent chemoradiotherapy for Squamous Cell Carcinoma of Head and Neck.
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Albumin-bound Paclitaxel Combined With Cisplatin Versus Docetaxel Combined With Cisplatin Induced Chemotherapy in Advanced Head and Neck Squamous Tummor [Phase 4]
A Phase 4 trial comparing albumin-bound paclitaxel plus cisplatin versus docetaxel plus cisplatin in advanced head and neck squamous cell ca…